IP Library Granted Patent US 10,138,509
Granted Patent B2
US 10,138,509 · App. 14/774,282 · Granted Nov 27, 2018

Method for generating a three-dimensional nucleic acid containing matrix

Inventors: George M. Church (Brookline, MA); Je-Hyuk Lee (Allston, MA); Richard C. Terry (Carlisle, MA); Evan R. Daugharthy (Cambridge, MA)
Assignee: President and Fellows of Harvard College
C12Q1/6806C12P19/34C12Q1/6844C12Q1/6869C12Q1/6874
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,138,509
App. No.
14/774,282
Granted
Nov 27, 2018
Kind
B2
Abstract

Methods of making a three-dimensional matrix of nucleic acids within a cell is provided.

Claims (55)

1. A method of identifying nucleic acids within a cell, comprising:

contacting a plurality of nucleic acids having a relative three-dimensional spatial relationship within the cell with a matrix-forming material in a manner to substantially retain the relative three-dimensional spatial relationship;

using the matrix-forming material to form a three-dimensional polymerized matrix including the nucleic acids of the plurality of nucleic acids covalently bound to the three-dimensional polymerized matrix; and

detecting signals from the nucleic acids or derivatives thereof, thereby identifying the nucleic acids.

2. The method of claim 1 further including the step of amplifying the nucleic acids to produce amplicons within the three-dimensional polymerized matrix.

3. The method of claim 2 further including the step of covalently bonding the amplicons to the three-dimensional polymerized matrix.

4. The method of claim 1 wherein the plurality of nucleic acids are contained within a biological sample and the matrix-forming material is introduced into the biological sample.

5. The method of claim 1 wherein the plurality of nucleic acids are contained within a cell and the matrix-forming material is introduced into the cell.

6. The method of claim 1 wherein the plurality of nucleic acids are contained within a tissue sample and the matrix-forming material is introduced into the tissue sample.

7. A method of identifying one or more nucleic acids within a cell comprising:

contacting a plurality of nucleic acids having a relative three-dimensional spatial relationship within the cell with a matrix-forming material to form a three-dimensional polymerized matrix comprising the plurality of nucleic acids coupled to the three-dimensional polymerized matrix, wherein the relative three-dimensional spatial relationship is substantially retained in the three-dimensional polymerized matrix;

amplifying the plurality of nucleic acids to produce amplicons within the three-dimensional polymerized matrix;

coupling the amplicons to the three-dimensional polymerized matrix; and

detecting the amplicons to identify a sequence of the one or more nucleic acids.

8. A method of identifying a relative three-dimensional spatial relationship of one or more nucleic acids within a cell comprising:

contacting a plurality of nucleic acids having the relative three-dimensional spatial relationship within the cell with a matrix-forming material in a manner to substantially retain the relative three-dimensional spatial relationship;

using the matrix-forming material to form a three-dimensional polymerized matrix including the plurality of nucleic acids covalently bound to the three-dimensional polymerized matrix;

amplifying the plurality of nucleic acids to produce amplicons within the matrix, covalently bonding the amplicons to the three-dimensional polymerized matrix;

labeling the amplicons with a detectable label; and

imaging the amplicons to identify the relative three-dimensional spatial relationship of the one or more nucleic acids within the cell.

9. The method of claim 7 wherein the plurality of nucleic acids are circular.

10. The method of claim 7 wherein the plurality of nucleic acids are contained within a biological sample and the matrix-forming material is introduced into the biological sample.

11. The method of claim 7 wherein the plurality of nucleic acids are contained within a cell and the matrix-forming material is introduced into the cell.

12. The method of claim 7 wherein the plurality of nucleic acids are contained within a tissue sample and the matrix-forming material is introduced into the tissue sample.

13. The method of claim 8 wherein the plurality of nucleic acids are contained within a biological sample and the matrix-forming material is introduced into the biological sample.

14. The method of claim 8 wherein the plurality of nucleic acids are contained within a cell and the matrix-forming material is introduced into the cell.

15. The method of claim 8 wherein the plurality of nucleic acids are contained within a tissue sample and the matrix-forming material is introduced into the tissue sample.

16. The method of claim 1 wherein the relative three-dimensional spatial relationship of each nucleic acid of the plurality of nucleic acids is immobilized within the three-dimensional polymerized matrix.

17. The method of claim 1 wherein the matrix-forming material comprises polyacrylamide, cellulose, alginate, polyamide, cross-linked agarose, cross-linked dextran or cross-linked polyethylene glycol.

18. The method of claim 7 wherein the relative three-dimensional spatial relationship of each nucleic acid of the plurality of nucleic acids is immobilized within the three-dimensional polymerized matrix.

19. The method of claim 8 wherein the relative three-dimensional spatial relationship of each nucleic acid of the plurality of nucleic acids is immobilized within the three-dimensional polymerized matrix.

20. The method of claim 7 wherein contacting the plurality of nucleic acids having the relative three-dimensional spatial relationship within the cell with the matrix-forming material comprises subjecting the matrix-forming material to a polymerization inducing catalyst, ultraviolet (UV) light, or functional cross-linkers.

21. The method of claim 7 wherein coupling the amplicons to the three-dimensional polymerized matrix comprises covalently bonding the amplicons to the three-dimensional polymerized matrix.

22. The method of claim 7 wherein the three-dimensional polymerized matrix comprises the plurality of nucleic acids covalently bound to the three-dimensional polymerized matrix.

23. The method of claim 7 wherein the amplicons are labeled with a detectable label.

24. The method of claim 1 , wherein the three-dimensional polymerized matrix is formed by subjecting the matrix-forming material to cross-linking.

25. The method of claim 1 , wherein the three-dimensional polymerized matrix is formed by subjecting the matrix-forming material to polymerization.

26. The method of claim 7 , wherein the three-dimensional polymerized matrix is formed by subjecting the matrix-forming material to cross-linking.

27. The method of claim 7 , wherein the three-dimensional polymerized matrix is formed by subjecting the matrix-forming material to polymerization.

28. The method of claim 8 , wherein the three-dimensional polymerized matrix is formed by subjecting the matrix-forming material to cross-linking.

29. The method of claim 8 , wherein the three-dimensional polymerized matrix is formed by subjecting the matrix-forming material to polymerization.

30. The method of claim 2 , wherein amplifying the nucleic acids comprises performing polymerase chain reaction (PCR) on the nucleic acids.

31. The method of claim 2 , wherein amplifying the nucleic acids comprises performing isothermal enzymatic amplification on the nucleic acids.

32. The method of claim 2 , wherein the amplicons are labeled with a detectable label.

33. The method of claim 7 , wherein amplifying the plurality of nucleic acids comprises performing PCR on the plurality of nucleic acids.

34. The method of claim 7 , wherein amplifying the plurality of nucleic acids comprises performing isothermal enzymatic amplification on the plurality of nucleic acids.

35. The method of claim 8 , wherein amplifying the plurality of nucleic acids comprises performing PCR on said plurality of nucleic acids.

36. The method of claim 8 , wherein amplifying the plurality of nucleic acids comprises performing isothermal enzymatic amplification on the plurality of nucleic acids.

37. The method of claim 1 , wherein the plurality of nucleic acids are circular.

38. The method of claim 8 , wherein the plurality of nucleic acids are circular.

39. The method of claim 1 , wherein the matrix-forming material is used to form the three-dimensional polymerized matrix subsequent to contacting the plurality of nucleic acids with the matrix-forming material.

40. The method of claim 7 , wherein each of the amplicons is coupled to the three-dimensional polymerized matrix upon formation.

41. The method of claim 8 , wherein the matrix-forming material is used to form the three-dimensional polymerized matrix subsequent to contacting the plurality of nucleic acids with the matrix-forming material.

42. The method of claim 1 , wherein detecting the signals comprises contacting a nucleic acid of the nucleic acids or derivatives thereof with a detectable label and detecting a signal from the detectable label.

43. The method of claim 1 , wherein detecting the signals comprises contacting a nucleic acid of the nucleic acids or derivatives thereof with a plurality of detectable labels and detecting signals from the plurality of detectable labels.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 6, 2017
From: CHURCH, GEORGE M.; DAUGHARTHY, EVAN R.; LEE, JEHYUK; TERRY, RICHARD C.
To: PRESIDENT AND FELLOWS OF HARVARD COLLEGE
Reel/Frame 041179/0241 →
CONFIRMATORY LICENSE Recorded Oct 19, 2015
From: HARVARD UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 036897/0339 →
Continuity (2)
Provisional Application 61777383 · Mar 12, 2013
Related Publication 20160024555A1 · Jan 28, 2016
Cited By (63)
US 12,188,085 US 12,195,790 US 12,203,136 US 12,209,273 US 12,209,275 US 12,234,507 US 12,252,740 US 12,258,623 US 12,258,624 US 12,264,358 US 12,270,074 US 12,270,077 US 12,281,356 US 12,286,666 US 12,286,667 US 12,325,877 US 12,331,347 US 12,344,892 US 12,359,253 US 12,360,105 US 12,365,936 US 12,365,944 US 12,372,771 US 12,378,607 US 12,385,083 US 12,391,984 US 12,391,988 US 12,404,544 US 12,421,541 US 12,421,558 US 12,435,364 US 12,442,045 US 12,460,251 US 12,467,086 US 12,486,532 US 12,497,653 US 12,497,654 US 12,509,717 US 12,510,744 US 12,516,369 US 12,529,093 US 12,529,094 US 12,529,096 US 12,545,949 US 12,553,079 US 12,559,790 US 12,565,671 US 12,577,611 US 12,580,044 US 12,581,050 US 12,613,253 US 12,618,099 US 12,630,869 US 12,644,837 US 12,646,340 US 12,655,474 US 12,668,835 US 12,669,438 US 12,674,196 US 12,692,484 US 12,703,879 US 12,709,771 US 12,716,092